Brief: Oryzon Gets "Decision To Grant" For Two Vafidemstat Patents In Japan

ORYZON Genomics SA

08/07/2024 07:10

July 8 (Reuters) - Oryzon Genomics SA  ORY.MC :
    * RECEIVES "DECISION TO GRANT" FOR TWO IMPORTANT PATENTS FOR
VAFIDEMSTAT IN JAPAN
    * APPLICATION REACHES STATUS WHERE IT IS ALLOWED FOR
ISSUANCE AS A
PATENT
    * PATENTS FOR TREATMENT OF BORDERLINE PERSONALITY DISORDER
(BPD)
AND ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
    * BOTH PATENTS, ONCE GRANTED, WILL NOT EXPIRE UNTIL AT LEAST
2040,
EXCLUDING ANY POTENTIAL PATENT TERM EXTENSIONS THAT MAY PROVIDE
ADDITIONAL PROTECTION

Source text: https://tinyurl.com/bdd8kccc
Further company coverage:  ORY.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))